Table of Contents How GLP-1 Medications Affect Gut Health in Women Glucagon-like peptide-1 (GLP-1) receptor agonists, such as semaglutide (Ozempic, Wegovy) and liraglutide (Saxenda, Victoza), are increasingly prescribed for type 2 diabetes management and weight loss
LQL, LLJ and JW contributed to the research design, manuscript drafting and overall manuscript revision process
Medical Disclaimer: This article is for educational purposes only and is not a substitute for medical advice, diagnosis, or treatment
Compared to semaglutide, those who took tirzepatide lost a greater percentage of body weight each month: an average of 5.9% of their body weight after 3 months, 10.1% after 6 months, and 15.3% after 12 months
Unlike medications that require precise timing around meals or sleep, retatrutide operates on a pharmacokinetic profile designed for once-weekly administration
Why quality varies so dramatically Peptide synthesis is a complex process